Amlodipine Besylate
Product Images NDC 67296-0672

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 67296-0672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Copy Of Label (6729606721)

Copy Of Label (6729606721)
A white rectangular label for Amlodipine Besylate 5 mg tablets, containing 30 tablets. The label includes the NDC number 67296-0672-1 and states 'Rx Only'. It provides storage instructions and manufacturer information, listing Greenstone LLC in Peapack, NJ as the manufacturer and Redpharm Drug in Eden Prairie, MN as the distributor. The label also shows lot number 100778 1 and an expiration date of 03/15, along with a barcode.*
FDA Label Image

Chemical Structure (Amlodipine 01)

Chemical Structure (Amlodipine 01)
Chemical structure of amlodipine besylate, showing its molecular arrangement including rings and functional groups.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A Kaplan-Meier survival curve comparing composite clinical outcomes over 24 months for amlodipine versus placebo. The x-axis shows time in months, and the y-axis shows the event rate. Two lines represent outcomes for amlodipine and placebo groups, with annotated sample sizes at various time points along the x-axis. A statistical inset displays p-value, hazard ratio, and confidence interval.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A forest plot titled 'Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups,' showing hazard ratios with 95% confidence intervals for different patient subgroups such as age, gender, baseline systolic blood pressure, and stent status. The x-axis ranges from 0.0 to 2.0, indicating the treatment effect favoring either amlodipine or placebo, with data points and confidence intervals for each subgroup listed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.